Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengwei Tan

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Journal of Thoracic Disease|March 15, 2021
Clinicopathological characteristics and prognostic factors of primary pulmonary lymphomaHuayu He, Fengwei Tan, Qi Xue, et al.
Translational Lung Cancer Research|August 12, 2022
Racial disparities in histological subtype, stage, tumor grade and cancer-specific survival in lung cancerHui Zeng, Zhenlong Yuan, Guochao Zhang, et al.
Journal of Thoracic Disease|January 15, 2021
Uniportal versus multiportal thoracoscopic sleeve lobectomy for the surgical treatment of centrally located lung cancer: a single institution experienceJun Zhao, Qingpeng Zeng, Jiagen Li, et al.
Journal of Thoracic Disease|November 18, 2024
Risk of treatment-related toxicity from EGFR tyrosine kinase inhibitors: a systematic review and network meta-analysis of randomized clinical trials in <i>EGFR</i>-mutant non-small cell lung cancerZhifei Li, Hongyuan Chu, Sicheng Huang, et al.
JAMA Oncology|January 15, 2026
Lymph Node Dissection Guideline Adherence and Survival in Patients With T1N0M0 Lung AdenocarcinomaRenda Li, Pan Wang, Hao Zhang, et al.
Cancer Communications (London, England)|December 2, 2020
Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?Zuyang Yuan, Xinfeng Wang, Xiao Geng, et al.
Chinese Medical Journal|March 20, 2025
Real-world long-term outcomes of non-small cell lung cancer patients undergoing neoadjuvant treatment with or without immune checkpoint inhibitorsBolun Zhou, Lin Li, Fan Zhang, et al.
Pharmacological Research|September 14, 2023
Plasma extracellular vesicle long RNAs predict response to neoadjuvant immunotherapy and survival in patients with non-small cell lung cancerWei Guo, Bolun Zhou, Liang Zhao, et al.
Translational Lung Cancer Research|February 17, 2025
Lobectomy plus lobe-specific lymphadenectomy as the minimum standards of curative resection for hypermetabolic clinical stage IA non-small cell lung cancerRunze Li, Zhifei Li, Peng Li, et al.
Cancer Science|November 27, 2021
Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinomaShugeng Gao, Wei Guo, Tiejun Liu, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Journal of Thoracic Disease|March 15, 2021
Clinicopathological characteristics and prognostic factors of primary pulmonary lymphomaHuayu He, Fengwei Tan, Qi Xue, et al.
Translational Lung Cancer Research|August 12, 2022
Racial disparities in histological subtype, stage, tumor grade and cancer-specific survival in lung cancerHui Zeng, Zhenlong Yuan, Guochao Zhang, et al.
Journal of Thoracic Disease|January 15, 2021
Uniportal versus multiportal thoracoscopic sleeve lobectomy for the surgical treatment of centrally located lung cancer: a single institution experienceJun Zhao, Qingpeng Zeng, Jiagen Li, et al.
Journal of Thoracic Disease|November 18, 2024
Risk of treatment-related toxicity from EGFR tyrosine kinase inhibitors: a systematic review and network meta-analysis of randomized clinical trials in <i>EGFR</i>-mutant non-small cell lung cancerZhifei Li, Hongyuan Chu, Sicheng Huang, et al.
JAMA Oncology|January 15, 2026
Lymph Node Dissection Guideline Adherence and Survival in Patients With T1N0M0 Lung AdenocarcinomaRenda Li, Pan Wang, Hao Zhang, et al.
Cancer Communications (London, England)|December 2, 2020
Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?Zuyang Yuan, Xinfeng Wang, Xiao Geng, et al.
Chinese Medical Journal|March 20, 2025
Real-world long-term outcomes of non-small cell lung cancer patients undergoing neoadjuvant treatment with or without immune checkpoint inhibitorsBolun Zhou, Lin Li, Fan Zhang, et al.
Pharmacological Research|September 14, 2023
Plasma extracellular vesicle long RNAs predict response to neoadjuvant immunotherapy and survival in patients with non-small cell lung cancerWei Guo, Bolun Zhou, Liang Zhao, et al.
Translational Lung Cancer Research|February 17, 2025
Lobectomy plus lobe-specific lymphadenectomy as the minimum standards of curative resection for hypermetabolic clinical stage IA non-small cell lung cancerRunze Li, Zhifei Li, Peng Li, et al.
Cancer Science|November 27, 2021
Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinomaShugeng Gao, Wei Guo, Tiejun Liu, et al.
Pageof 16